Open AccessEstablishing an Anti-Müllerian hormone cutoff for diagnosis of polycystic ovarian syndrome in women of reproductive age-bearing Indian ethnicity using the automated Anti-Müllerian hormone assay
Author(s) -
Nalini Mahajan,
Jasneet Kaur
Publication year - 2019
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/jhrs.jhrs_149_18
Subject(s) - anti müllerian hormone , medicine , polycystic ovary , antral follicle , gynecology , ovarian reserve , infertility , intracytoplasmic sperm injection , in vitro fertilisation , obstetrics , hormone , endocrinology , pregnancy , biology , insulin resistance , insulin , genetics
Polycystic ovary syndrome diagnosed by Rotterdam criteria, is the most common cause of anovulatory infertility. The criteria of polycystic ovarian morphology (PCOM) are subject to operator variability and technological advances. Serum anti-Müllerian hormone (AMH) level has been proposed as a more reliable alternative to antral follicle count. There is a paucity of data on use of AMH for diagnosis of PCOS in Indian women.